{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04155",
    "Peptide Name": "SE-33-A2P (hybrid peptide, synthetic AMPs, UCll1)",
    "Source": "hybrid peptide hybrid peptide, designed",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "SETRPVLNRLFRLFDKIRQVIRQVIRKFEKGIKEKSKRFFEGRGSLLTCGDVEENPGP",
    "Sequence Length": 58,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 6,
    "Boman Index": 2.91,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "33%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is most similar (56.9%) toSE-33The A2P peptide (EGRGSLLTCGDVEENPGP), a self-cleaving peptide, is attached to the end of SE-33 peptide for multiple-copy expression. This expression is toxic to E. coli.Activity: active against E. coli (MIC 35-45 ug/ml), S. aureus (MIC 35 ug/ml), and L. casei (MIC 30-35 ug/ml).",
    "Author": "Gasanov V, Vorotelyak E, Vasiliev A. 2024",
    "Reference": "Antibiotics (Basel). 2024 Feb 16;13(2):190. doi: 10.3390/antibiotics13020190.PubMed",
    "Title": "Expression of the Antimicrobial Peptide SE-33-A2P, a Modified Analog of Cathelicidin, and an Analysis of Its Properties."
  },
  "3D Structure": []
}